Hemosol Corp.

Description

Hemosol BioPharma Inc. is a privately held specialty biopharmaceutical company wholly owned by Catalyst Fund Limited Partnership II. The Company is focused primarily on the development and manufacture of blood related protein based therapeutic products. The Company's activities are focused in the following three areas: - Implementation of the "Cascade" technology for the isolation and purification of plasma proteins. This disruptive technology has the potential to change the business dynamics of the therapeutic plasma proteins sector. - Providing clients with bio-manufacturing and aseptic filling services from the Company's state-of-the-art 130,000 sqft manufacturing facility. - Commercialization of the Company's rich and diverse product Pipeline that encompasses three broad technology platforms, including oxygen therapeutics, drug delivery products and cell therapeutics (growth factors). In addition to these three core business areas, Hemosol BioPharma Inc. has an active licensing partnership and acquisition program. The company is currently actively seeking partnerships, licensing, and / or product or company acquisition opportunities aimed at complementing its existing operations.

Company contacts

Products & services

Similar companies nearby